Fifth Circuit Court of Appeals Determines that FDA’s 2016 and 2021 Changes to Mifepristone Were Unlawful
Today, a three-judge panel of the Fifth Circuit Court of Appeals, in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA), determined that when the FDA loosened regulations in 2016 and 2021 regarding the drug mifepristone, it did so unlawfully, failing to give adequate consideration to demonstrated safety issues with the drug. Today’s […]